Neonatal Hypoxic-Ischemic Encephalopathy: Advances in Therapeutic Hypothermia and Biomaker Research
Keywords:
Antioxidants, Biomarkers, Encephalopathy, Hypoxia, Inflammation, Magnetic Resonance Imaging, Neonatal Brain Injury, Neurodevelopment, Oxidative Stress, Therapeutic Hypothermia, Urinary Biomarkers, White MatterAbstract
Neonatal hypoxic-ischemic encephalopathy (HIE) is a serious condition resulting from insufficient oxygen and blood flow to the neonatal brain, leading to significant morbidity and mortality worldwide. Therapeutic hypothermia (TH) remains the only established treatment, offering neuroprotection by reducing cerebral metabolism, excitotoxicity, and inflammation, thereby improving survival and neurological outcomes. However, despite its benefits, a substantial proportion of infants treated with TH still experience death or long-term neurodevelopmental disabilities, highlighting the need for optimized therapies and adjunctive treatments. Recent advances have focused on understanding the complex pathophysiology of HIE, including phases of primary and secondary energy failure, oxidative stress, and neuroinflammation, which are critical for guiding intervention timing and development. Concurrently, biomarker research is rapidly evolving to identify reliable indicators of brain injury severity and progression, with promising candidates including neuroproteins, microRNAs, and inflammatory mediators. These biomarkers aim to enable early diagnosis, prognostication, and personalized treatment strategies. This review summarizes current therapeutic hypothermia protocols, explores novel adjunct therapies under clinical evaluation, and highlights emerging biomarker discoveries that hold potential to transform the management and outcomes of neonatal HIE. Further research and clinical trials are essential to improve neuroprotection and reduce the long-term impacts of HIE.
Downloads
Metrics
References
Muniraman, H. K., Donn, S. M., & Short, B. L. (2017). Hepatic biomarkers in neonates with hypoxic-ischemic encephalopathy and the effect of therapeutic hypothermia. Journal of Perinatology, 37(5), 539–544. https://doi.org/10.1038/jp.2016.260
Chalak, L. F., Nguyen, K. A., Prempunpong, C., Heyne, R. J., & Sanchez, P. J. (2014). Early biomarkers of hypoxic-ischemic encephalopathy and the effects of therapeutic hypothermia. Pediatric Research, 76(1), 93–100. https://doi.org/10.1038/pr.2014.61
Massaro, A. N., Bammler, T. K., MacDonald, J. W., & McKnight, R. A. (2012). Plasma biomarkers of brain injury in neonatal hypoxic-ischemic encephalopathy. Journal of Pediatrics, 161(4), 671–677. https://doi.org/10.1016/j.jpeds.2012.03.004
Sweetman, D. U., Cleary, G., O’Donnell, C. P. F., & Molloy, E. J. (2016). Serum and urinary biomarkers of acute kidney injury in neonatal encephalopathy. Pediatric Nephrology, 31(4), 595–602. https://doi.org/10.1007/s00467-015-3254-2
Shastri, A. T., & Sira, J. (2012). Cardiac troponin I levels in neonates with hypoxic-ischemic encephalopathy. Indian Pediatrics, 49(4), 297–299. https://doi.org/10.1007/s13312-012-0060-1
Jacobs, S. E., Berg, M., Hunt, R., Tarnow-Mordi, W. O., Inder, T. E., & Davis, P. G. (2013). Cooling for newborns with hypoxic ischaemic encephalopathy. Cochrane Database of Systematic Reviews, (1), CD003311. https://doi.org/10.1002/14651858.CD003311.pub3Wikipedia
Gluckman, P. D., Wyatt, J. S., Azzopardi, D., Ballard, R., Edwards, A. D., Ferriero, D. M., ... & Gunn, A. J. (2005). Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial. The Lancet, 365(9460), 663–670. https://doi.org/10.1016/S0140-6736(05)17946-XWikipedia
Shankaran, S., Laptook, A. R., Ehrenkranz, R. A., Tyson, J. E., McDonald, S. A., Donovan, E. F., ... & Higgins, R. D. (2005). Whole-body hypothermia for neonates with hypoxic–ischemic encephalopathy. New England Journal of Medicine, 353(15), 1574–1584. https://doi.org/10.1056/NEJMcps050929
Satriano, R. A., & Shapiro, S. M. (2017). Biomarkers for neonatal hypoxic-ischemic encephalopathy: past, present, and future. Pediatric Neurology, 77, 3–9. https://doi.org/10.1016/j.pediatrneurol.2017.08.001
Heljic, S., & Avdagic, E. (2018). Blood lactate levels as a prognostic marker in neonates with hypoxic-ischemic encephalopathy. Medical Archives, 72(1), 20–23. https://doi.org/10.5455/medarh.2018.72.20-23
Shah, D. K., Wusthoff, C. J., Clarke, P., Wyatt, J. S., & Cowan, F. M. (2018). Electroencephalography and magnetic resonance imaging in hypoxic-ischemic encephalopathy. Seminars in Fetal and Neonatal Medicine, 23(4), 234–241. https://doi.org/10.1016/j.siny.2018.04.002
Li, L., Zhang, X., & Zhang, Y. (2020). Therapeutic hypothermia inhibits inflammation and apoptosis in a neonatal rat model of hypoxic-ischemic encephalopathy. Brain Research, 1727, 146547. https://doi.org/10.1016/j.brainres.2019.146547
Douglas-Escobar, M., & Weiss, M. D. (2010). Biomarkers of hypoxic-ischemic encephalopathy in newborns. Frontiers in Bioscience (Elite Edition), 2, 47–63. https://doi.org/10.2741/e77
Wintermark, P., Hansen, A., Warfield, S. K., Dukhovny, D., Soul, J. S., & Volpe, J. J. (2014). Near-infrared spectroscopy versus magnetic resonance imaging to assess brain injury in newborns undergoing therapeutic hypothermia. Journal of Pediatrics, 164(4), 696–701. https://doi.org/10.1016/j.jpeds.2013.11.027
Baserga, M. C., & Bauer, C. R. (2015). Early blood gas predictors of hypoxic-ischemic encephalopathy in term infants. Journal of Perinatology, 35(7), 529–533. https://doi.org/10.1038/jp.2015.17
..
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.